Form S-3 - Registration statement under Securities Act of 1933:
SEC Accession No. 0001640334-24-001793
Filing Date
2024-11-26
Accepted
2024-11-26 16:38:36
Documents
7

Document Format Files

Seq Description Document Type Size
1 FORM S-3 lxrp_s3.htm S-3 186489
2 OPINION lxrp_ex51.htm EX-5.1 8411
3 CONSENT lxrp_ex231.htm EX-23.1 2131
4 FILING FEE TABLE lxrp_ex107.htm EX-FILING FEES 16206
5 lxrp_ex51img1.jpg GRAPHIC 7105
6 lxrp_s3img3.jpg GRAPHIC 4983
7 lxrp_s3img4.jpg GRAPHIC 4976
  Complete submission text file 0001640334-24-001793.txt   238284
Mailing Address 100 - 740 MCCURDY ROAD KELOWNA A1 V1X 2P7
Business Address 100 - 740 MCCURDY ROAD KELOWNA A1 V1X 2P7 250-765-6424
Lexaria Bioscience Corp. (Filer) CIK: 0001348362 (see all company filings)

EIN.: 202000871 | State of Incorp.: NV | Fiscal Year End: 0831
Type: S-3 | Act: 33 | File No.: 333-283484 | Film No.: 241504582
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)